14 results
425
OncoMed Pharmaceuticals Inc
6 Dec 18
Business combination disclosure
2:27pm
is undertaking a restructuring that will involve a significant reduction in its workforce, while maintaining a core employee base to meet
6-K
EX-99.2
MREO
Mereo Biopharma Group Plc
21 Oct 22
Mereo BioPharma Files Shareholder Circular for Upcoming General Meeting
7:06am
the regulatory, scientific, clinical, partnering and competitive landscape best. Our workforce is extremely mobile and highly sought after
DEF 14A
MREO
Mereo Biopharma Group Plc
24 Apr 24
Definitive proxy
7:30am
workforce, as well as employee pay conditions more broadly in comparison to our peer group companies and inflation. Where there has been a change
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
or traveling outside of the U.K.;
workforce uncertainty in countries where labor unrest is more common than in the U.K.;
difficulties associated … and intrusions from around the world have increased. In addition, varying parts of our workforce are currently working remotely on a part or full time basis
F-4
EX-10.24
MREO
Mereo Biopharma Group Plc
25 Jan 19
Registration of securities (foreign)
12:00am
disturbance involving the workforce of thenon-performing Party where such event is within the reasonable control of thenon-performing Party), acts of God
20-F
px6okmo2wwxn8ze6b12d
29 Apr 19
Annual report (foreign)
4:59pm
F-4/A
ru3u77 6rsazltka
15 Mar 19
Registration of securities (foreign) (amended)
5:08pm
F-4
9e431u70dkg5dpvv
25 Jan 19
Registration of securities (foreign)
12:00am
F-1/A
nycf8
12 Mar 20
Registration statement (foreign) (amended)
5:15pm
F-1/A
5qnvgv4bz2erqypt
6 Mar 20
Registration statement (foreign) (amended)
5:32pm
424B3
kcsmw v817bve8w
20 Mar 19
Prospectus supplement
4:58pm
- Prev
- 1
- Next